Avacta confirms China patent for Affimer technology
Shares in Avacta Group are up more than 5% after it said the principal patent protecting the Affimer technology has been accepted for grant in the People's Republic of China.
Avacta Group
51.50p
16:55 27/09/24
4.04%
2.00p
FTSE AIM All-Share
745.65
17:14 27/09/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,314.18
17:10 27/09/24
0.05%
10.16